Tirzepatide and semaglutide are popular weight loss drugs. Learn how they differ in effectiveness, cost, and side effects.
Two phase 3b trials evaluated the efficacy and safety of tirzepatide or orforglipron for weight maintenance after injectable incretin treatment.
Mounjaro and Zepbound are two brand-name glucagon-like peptide-1 (GLP-1) medications manufactured by Eli Lilly. Although they ...
Lake Oswego, Portland--(Newsfile Corp. - May 6, 2026) - Functional Brands Inc. (NASDAQ: MEHA), a pioneer in next-generation health and wellness solutions, today announced the official launch of ...
Scripps case series suggests some patients can maintain GLP-1 weight loss by spacing semaglutide or tirzepatide doses.
The study adds evidence that obesity treatment benefits depend on continued therapy, even when the delivery method changes.
Add Yahoo as a preferred source to see more of our stories on Google. Users of GLP-1 weight loss drugs now have a choice: injections or pills. There are multiple drug choices within each category, but ...
Injectable weight-loss drugs like Ozempic and Mounjaro are being seen as a quick-fix for minor weight loss — even if they’re supposed to be prescribed for those with obesity and diabetes. "I didn't ...
If you’re weighing the option of Wegovy versus Zepbound for weight loss, here’s how the two medications compare in terms of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results